stella
beta
Efficacy and Safety of Dose Redution of Radotinib as a First Line Treament in Ph+ CML — Stella
Recruiting
Back to Chronic Phase Ph+ Chronic Myeloid Leukemia trials
Trial locations
(2 sites)
South Korea
Hallym University Sacred Heart Hosptial, Anyang-si, Gyeonnggi-do
Keimyung University Daegu Dongsan Hospital, Daegu
View full record on ClinicalTrials.gov